Technology
Gilead’s New Daily HIV Pill, Bixlenvo, Approved by FDA to Simplify Treatment Regimens
The FDA has approved Gilead Sciences' new once-daily HIV pill, Bixlenvo, which combines key…
By
Market VOWS
Salesforce’s Post-Earnings Surge: Chart Analysis Points to Major Breakout and Significant Upside Potential
Salesforce has experienced a significant post-earnings breakout, marked by a price gap higher, signaling…
By
Market VOWS
After-Hours Buzz: Nvidia Soars, Salesforce Climbs as Tech Giants Beat Expectations
Nvidia and Salesforce were among the top movers in after-hours trading, with both tech…
By
Market VOWS
Meta Stock Surges on $18 Billion Child-Safety Settlement, Eyes AI Future
Meta Platforms (NASDAQ:META) stock rose 1.07% to $576.14 after agreeing to an $18 billion…
By
Market VOWS